KPIs & Operating Metrics(New)

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Accured Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Twist Bioscience (TWST) Preferred Shares Issued (2017 - 2018)

Twist Bioscience has reported Preferred Shares Issued over the past 2 years, most recently at $7.0 million for Q3 2018.

Quarterly Preferred Shares Issued changed N/A to $7.0 million in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $90.8 million through Sep 2018, changed N/A year-over-year, with the annual reading at $90.8 million for FY2018, 38.5% up from the prior year.
Preferred Shares Issued was $7.0 million for Q3 2018 at Twist Bioscience, down from $24.9 million in the prior quarter.
Over five years, Preferred Shares Issued peaked at $56.0 million in Q1 2018 and troughed at $3.0 million in Q4 2017.